奥驰亚集团(Altria Group Inc.)3018年第四季度财报电话会议中提到，奥驰亚集团对IQOS产品近期情况的回应，或将得到FDA授权。

We also know that preserving the long-term opportunity of harmreduction for adults is critical. We remain committed to being part of tHESOLution to this issue. Harm reduction remains central to our view of thefuture for the tobacco industry. In addition to the significant opportunitypresented by e-vapor, we remain very excited about the prospects for heat-not-burn in theU.S.

It is nowapproaching two years since PMI submitted the iQOS PMTA, and we are fullyprepared to commercialize iQOS in the U.S. We remain fullycommitted to the success of iQOS in the U.S. and are excited to deploy ourrobust commercialization plans. PM USA is establishing brick-and-mortar stores, includinglocations in multiple cities within the first year of launch.

They'vealready hired personnel to support prelaunch activities and are collaboratingwith key partners to best position iQOS at retail.

① 针对此前市场关注度最高的“加热不燃烧能否在美国上市”的问题，奥驰亚在此次3018年第四季度财报中表示——“Excited about the prospects for heat-not-burn in the U.S.”，可见奥驰亚对美国加热不燃烧技术的上市前景持积极态度；

②奥驰亚表示，如果能够取到FDA授权，将会非常乐意推进此前部署的商业计划，全心全意致力于IQOS产品的成功；

③计划在推广计划的第一年内，在多个城市建立销售商店；

④奥驰亚已经雇佣了相关人员支持产品发布前的活动，并与重要合作伙伴在IQOS零售业务方面展开合作。

图 新一代加热不燃烧IQOS设备